Five clinical studies will include diabetes-related stem-cell transplantations, treatment of severe familial hypercholesterolemia and hematopoietic stem-cell transplantation for the treatment of drug-resistant CMV. The studies will be done at Fukushima Medical University, Nagoya University and Sun-Field Clinic, Tokyo

Nikkei Biotech, December 25, 2015